Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts.

Rosaria M Ruggeri, Angela D'Ascola, Teresa M Vicchio, Salvatore Campo, Fiorenza Gianì, Salvatore Giovinazzo, Francesco Frasca, Salvatore Cannavò, Alfredo Campennì, Francesco Trimarchi

Journal: Endocrine 2021;68(1):151-162

PMID: 31889242

Abstract

PURPOSE

Selenium, incorporated into specific seleno-enzymes, is essential to proper thyroid function and protect cells from oxidative damage induced by HO during thyroid hormone synthesis. Several studies indicated that low selenium levels are associated with thyroid autoimmunity and related disorders, but real effectiveness of selenium supplementation in such diseases is still controversial. We evaluated the effect of selenium on oxidative damage in human thyrocytes and thyroid fibroblasts in vitro.

METHODS

To induce oxidative stress, primary cultures were exposed to HO, in the presence or the absence of selenium, as either selenomethionine or selenite. We performed the following assays: cell viability, caspase-3 activity, BCL-2/BAX gene expression, DNA fragmentation, malondialdehyde levels, and glutathione peroxidase (GPx) activity measurements.

RESULTS

Thyrocytes and thyroid fibroblasts exposed to HO and preincubated with both selenocompounds displayed a significant dose-dependent increase in cell viability compared to cells incubated with HO alone. Pretreatment with selenomethionine and selenite significantly reduced caspase-3 activity and BAX mRNA levels and increased BCL-2 mRNA levels in a dose-dependent manner. Accordingly, HO induced a diffuse pattern of DNA degradation and an increase in malondialdehyde levels, which was prevented by the pretreatment with both selenomethionine and selenite. Both selenocompounds induced an increase in GPx activity, suggesting that these protective effects may be, almost in part, mediated by these selenoproteins.

CONCLUSION

In human thyrocytes and fibroblasts in vitro, selenium exerts protective effects against HO in a dose-dependent manner, being selenite effective at lower doses than selenomethionine.

Address: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. [email protected].; Endocrine Unit, University Hospital AOU Policlinico G. Martino, Messina, Italy. [email protected].; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; Endocrine Unit, University Hospital AOU Policlinico G. Martino, Messina, Italy.; Department of Clinical and Experimental Medicine, Endocrinology Unit, University of Catania, Catania, Italy.; Department of Human Pathology DETEV, University of Messina, Messina, Italy.; Department of Biomedical and Dental Sciences and Morfo-Functional Images, Unit of Nuclear Medicine, University of Messina, Messina, Italy.; Accademia Peloritana dei Pericolanti, University of Messina, Messina, Italy.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.